cat no | io1007
ioGlutamatergic Neurons
GBA null/WT™
Human iPSC-derived Gaucher and Parkinson’s disease model
ioGlutamatergic Neurons GBA null/WT are opti‑ox™ precision reprogrammed glutamatergic neurons carrying a genetically engineered heterozygous knockout of the GBA gene encoding the glucocerebrosidase (GCase) enzyme. The cells offer a suitable model to study the molecular and cellular processes seen in Gaucher and Parkinson’s diseases.
Related disease model cells are coming soon with a heterozygous PRKN R275W or a homozygous PRKN R275W mutation. All can be used alongside their genetically matched control, ioGlutamatergic Neurons™.
Coming Soon
Register your interest, and we will notify you as soon as the product is available.
Benchtop benefits
Make True Comparisons
Pair the ioDisease Model Cells with the genetically matched wild-type ioGlutamatergic Neurons to investigate the impact of the mutation.
Scalable
With opti-ox technology, we can make billions of consistently reprogrammed cells, surpassing the demands of industrial workflows.
Quick
The disease model cells and isogenic control are experiment ready as early as 2 days post revival, and form structural neuronal networks at 11 days.
Running Large-Scale CRISPR Screens in Human Neurons
Watch now
Hoescht(blue)TUBB3(blue)_day4.jpg?width=604&name=bit.bio_ioGlutamatergic%20Neurons_60xMAP2(red)Hoescht(blue)TUBB3(blue)_day4.jpg)
Addressing the Reproducibility Crisis | Driving Genome-Wide Consistency in Cellular Reprogramming
Watch now
Industrialising Cellular Reprogramming: Leveraging opti-ox™ Technology to Manufacture Human Cells with Unprecedented Consistency
Watch now
Modelling neurodegeneration: Human isogenic system to study FTD & ALS
Download
Hoescht(blue)_day12v2.png?width=604&name=bit.bio_ioGlutamatergic%20Neurons_20xMAP2(red)Hoescht(blue)_day12v2.png)
Rethinking Developmental Biology With Cellular Reprogramming
Watch now
.png?width=604&name=Tech%20Nets%20online%20symposium%20header%20(1).png)
Precision Cellular Reprogramming for Scalable and Consistent Human Neurodegenerative Disease Models
Watch now
Development and characterisation of a robust in vitro disease model to study tauopathies
Download
Addressing current challenges of in vitro cell models
Read this blog to find out how experts from across academia and industry are approaching the challenges of reproducibility of in vitro cell models as well as potential solutions.
ioWild Type
ioGlutamatergic Neurons™
cat no. io1001
Order now
ioCRISPR-Ready
CRISPR-Ready ioGlutamatergic Neurons™
cat no. ioEA1090
Order now
ioDisease Model
ioGlutamatergic Neurons PRKN R275W/WT™
cat no. io1013
Order now
ioDisease Model
ioGlutamatergic Neurons PRKN R275W/R275W™
cat no. io1020
Order now
ioDisease Model
ioGlutamatergic Neurons HTT 50CAG/WT™
cat no. ioEA1004
Order now
ioDisease Model
ioGlutamatergic Neurons MAPT N279K/WT™
cat no. io1009
Order now
ioDisease Model
ioGlutamatergic Neurons MAPT P301S/WT™
cat no. io1015
Order now
ioDisease Model
ioGlutamatergic Neurons TDP‑43 M337V/WT™
cat no. ioEA1006
Order now
ioDisease Model
ioGlutamatergic Neurons MAPT N279K/N279K™
cat no. io1014
Order now
ioDisease Model
ioGlutamatergic Neurons MAPT P301S/P301S™
cat no. io1018
Order now
ioDisease Model
ioGlutamatergic Neurons TDP‑43 M337V/M337V™
cat no. ioEA1005
Order now
Wild Type and Isogenic Disease Model cells: A true comparison.
Further your disease research by pairing our wild type cells with isogenic disease models.
